Shivangi Remedies Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 17-12-2024
- Paid Up Capital ₹ 5.26 M
as on 17-12-2024
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 32.05 Cr
as on 17-12-2024
- Revenue -46.57%
(FY 2020)
- Profit -109.39%
(FY 2020)
- Ebitda -425.00%
(FY 2020)
- Net Worth -0.01%
(FY 2020)
- Total Assets -0.20%
(FY 2020)
About Shivangi Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.26 M.
The company has closed loans amounting to ₹32.05 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sakshi Jain and Tanya Jain serve as directors at the Company.
- CIN/LLPIN
U24232UP1996PTC072329
- Company No.
072329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 1996
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shivangi Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sakshi Jain  | Director | 15-Apr-2021 | Current |
| Tanya Jain | Director | 25-Oct-2023 | Current |
Financial Performance and Corporate Structure Insights of Shivangi Remedies.
Shivangi Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 46.57% decrease. The company also saw a substantial fall in profitability, with a 109.39% decrease in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shivangi Remedies?
In 2020, Shivangi Remedies had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rajhans Enterprises Private LimitedActive 11 years 11 monthsSakshi Jain and Tanya Jain are mutual person
Cosy Pharmaceuticals Private LimitedActive 38 years 10 monthsSakshi Jain and Tanya Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 31 Oct 2008 | ₹29.00 Cr | Satisfied |
Punjab National Bank Creation Date: 24 Jan 2005 | ₹1.40 Cr | Satisfied |
Punjab National Bank Creation Date: 23 Dec 2004 | ₹1.40 Cr | Satisfied |
How Many Employees Work at Shivangi Remedies?
Unlock and access historical data on people associated with Shivangi Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shivangi Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivangi Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
